DK2839836T4 - Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom - Google Patents

Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom Download PDF

Info

Publication number
DK2839836T4
DK2839836T4 DK14186663.2T DK14186663T DK2839836T4 DK 2839836 T4 DK2839836 T4 DK 2839836T4 DK 14186663 T DK14186663 T DK 14186663T DK 2839836 T4 DK2839836 T4 DK 2839836T4
Authority
DK
Denmark
Prior art keywords
probiotics
respiratory disease
reducing symptoms
symptoms
reducing
Prior art date
Application number
DK14186663.2T
Other languages
English (en)
Other versions
DK2839836T3 (da
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Int N&H Denmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2839836(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Int N&H Denmark Aps filed Critical Int N&H Denmark Aps
Publication of DK2839836T3 publication Critical patent/DK2839836T3/da
Application granted granted Critical
Publication of DK2839836T4 publication Critical patent/DK2839836T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14186663.2T 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom DK2839836T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02
EP07838266.0A EP2068899B1 (en) 2006-10-02 2007-09-14 Lactobacillus acidophilus for use in reducing the incidence and duration of respiratory infections

Publications (2)

Publication Number Publication Date
DK2839836T3 DK2839836T3 (da) 2017-12-04
DK2839836T4 true DK2839836T4 (da) 2024-08-26

Family

ID=39268947

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14186663.2T DK2839836T4 (da) 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom
DK07838266.0T DK2068899T3 (da) 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07838266.0T DK2068899T3 (da) 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner

Country Status (13)

Country Link
US (5) US20100040579A1 (da)
EP (2) EP2068899B1 (da)
JP (3) JP5896589B2 (da)
KR (2) KR101485200B1 (da)
CN (1) CN101528244B (da)
AU (1) AU2007302715B2 (da)
BR (1) BRPI0719787A2 (da)
DK (2) DK2839836T4 (da)
ES (2) ES2650375T5 (da)
FI (1) FI2839836T4 (da)
MX (1) MX2009003260A (da)
PL (2) PL2068899T3 (da)
WO (1) WO2008042101A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5538554B2 (ja) 2009-12-02 2014-07-02 ケーエムダブリュ・インコーポレーテッド デバイス選択構造
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN107427054A (zh) 2015-03-05 2017-12-01 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
US20200289804A1 (en) 2019-02-21 2020-09-17 Olympus Corporation Flora treatment
EP4040984B1 (en) 2019-09-25 2026-02-18 Tall Goods, LLC Methods for producing probiotics fortified avian eggs and egg products and formulations thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
AU5113798A (en) * 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
EP1549151A1 (en) 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
AU2004298384A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) † 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2348403T3 (es) * 2005-02-15 2010-12-03 Barry R. Goldin Un alimento que contiene un probiotico y un beta-glucano aislado y metodos de uso del mismo.
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases

Also Published As

Publication number Publication date
PL2839836T5 (pl) 2025-11-17
US20100040579A1 (en) 2010-02-18
WO2008042101A3 (en) 2009-04-09
AU2007302715B2 (en) 2013-01-31
DK2839836T3 (da) 2017-12-04
JP2010505824A (ja) 2010-02-25
CN101528244A (zh) 2009-09-09
PL2068899T3 (pl) 2015-12-31
JP5896589B2 (ja) 2016-03-30
CN101528244B (zh) 2012-01-11
JP2014058558A (ja) 2014-04-03
KR20090063222A (ko) 2009-06-17
KR20140002069A (ko) 2014-01-07
US20180000875A1 (en) 2018-01-04
DK2068899T3 (da) 2015-09-28
BRPI0719787A2 (pt) 2014-11-25
US20230256037A1 (en) 2023-08-17
PL2839836T3 (pl) 2018-02-28
EP2068899A2 (en) 2009-06-17
MX2009003260A (es) 2009-05-11
AU2007302715A1 (en) 2008-04-10
FI2839836T4 (fi) 2024-08-26
EP2839836A1 (en) 2015-02-25
EP2068899B1 (en) 2015-07-01
ES2650375T5 (en) 2025-02-03
US20140356329A1 (en) 2014-12-04
KR101485200B1 (ko) 2015-01-26
EP2839836B2 (en) 2024-06-26
KR101474188B1 (ko) 2014-12-17
ES2650375T3 (es) 2018-01-18
WO2008042101A2 (en) 2008-04-10
ES2547480T3 (es) 2015-10-06
EP2839836B1 (en) 2017-08-30
JP2016128478A (ja) 2016-07-14
US20200316145A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
DK2839836T4 (da) Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom
EP2114498A4 (en) INHALER
EP2142239A4 (en) INHALATION DEVICE
DK1986650T3 (da) Manipulationssikre doserignsformer
ITMI20060184U1 (it) Deambulatore magico
EP2112937A4 (en) NOSE MASK
EP2019911A4 (en) PULMONARMATRATZE
DK2077729T3 (da) Orale probiotiske doseringsformer
EP3777939C0 (en) NASAL ROYALTY
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
EP2025266A4 (en) CUSHION DEVICE
EP2004372A4 (en) Composite mandrel
DK2035369T3 (da) Terapeutiske
HRP20141261T1 (xx) Spojevi tioninija i njihove uporabe
DE602007013317D1 (de) Inhalator
DK2033675T3 (da) Inhalationsapparat
DK2056858T3 (da) Behandling af lungesygdomstilstande
DE602007008629D1 (de) Reißverschluss
BRPI0814248A2 (pt) Inalador
BRPI0714318A2 (pt) Utilização de 2-benzoil-imidazopiridinas em terapêutica
BRPI0814814A2 (pt) Inalador
UY3699Q (es) Dispositivo inhalador
FR2903717B1 (fr) Marchepied amovible et autoverrouillable
FI20065360A0 (fi) Rinnakkaisten mediavirtojen parannettu käyttö
CN300748666S (zh) 吸入器